Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
1.911
-0.039 (-2.02%)
Mar 31, 2025, 10:38 AM EDT - Market open
Intensity Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$8.50
Upside
+344.86%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +344.86% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +161.68% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +161.68% | Oct 31, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +528.04% | Jul 11, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +528.04% | May 16, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +528.04% | Mar 21, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +528.04% | Nov 14, 2023 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +528.04% | Aug 24, 2023 |
| Benchmark | Benchmark | Buy Initiates $12 | Buy | Initiates | $12 | +528.04% | Jul 18, 2023 |